Top

European Journal of Clinical Microbiology & Infectious Diseases

Published in:

01-09-2012 | Article

Viral and bacterial aetiologies of epithelial ovarian cancer

Authors: S. Shanmughapriya, G. SenthilKumar, K. Vinodhini, B. C. Das, N. Vasanthi, K. Natarajaseenivasan

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 9/2012

Abstract

We sought to analyse the presence of human papillomavirus (HPV), Chlamydia trachomatis and cytomegalovirus (CMV) infection in women with epithelial ovarian carcinomas. Polymerase chain reaction (PCR)-based detection of microbial infections was carried out. A total of 39 tissue samples were analysed with consensus and type-specific primers for HPV, primers specific for the cryptic plasmid of Chlamydia and primers for glycoprotein B of CMV. The samples analysed showed 40%, 80% and 50% positivity for HPV, Chlamydia and CMV infection, respectively, in cancerous ovarian tissues. The HPV type detected was HPV 6, with its genome integrated to the host genome in case of both invasive and borderline tumours and existed episomally in healthy controls. The patients with Chlamydia (odds ratio [OR] 32; 95% confidence interval [CI] 3.33, 307.65) and CMV infection (OR 8; 95% CI 0.888, 72.10) are at significantly higher risk of development of ovarian tumours. The present study validates the theory of chronic infections and inflammation in the pathogenesis of epithelial ovarian cancer. Further seroepidemiological studies and large fresh tissue sampling may represent the real prevalence of infections among ovarian carcinoma patients. This study is the first of its kind in detecting the bacterial and viral aetiologies in the development of ovarian carcinoma among Indian women.

Posadas EM, Davidson B, Kohn EC (2004) Proteomics and ovarian cancer: implications for diagnosis and treatment: a critical review of the recent literature. Curr Opin Oncol 16:478–484PubMedCrossRef

Berchuck A, Heron KA, Carney ME, Lancaster JM, Fraser EG, Vinson VL, Deffenbaugh AM, Miron A, Marks JR, Futreal PA, Frank TS (1998) Frequency of germline and somatic BRCA1 mutations in ovarian cancer. Clin Cancer Res 4:2433–2437PubMed

Idahl A, Lundin E, Jurstrand M, Kumlin U, Elgh F, Ohlson N, Ottander U (2011) Chlamydia trachomatis and Mycoplasma genitalium plasma antibodies in relation to epithelial ovarian tumors. Infect Dis Obstet Gynecol 2011:824627. doi:10.1155/2011/824627

Moss SF, Blaser MJ (2005) Mechanisms of disease: inflammation and the origins of cancer. Nat Clin Pract Oncol 2:90–97PubMedCrossRef

Koskela P, Anttila T, Bjørge T, Brunsvig A, Dillner J, Hakama M, Hakulinen T, Jellum E, Lehtinen M, Lenner P, Luostarinen T, Pukkala E, Saikku P, Thoresen S, Youngman L, Paavonen J (2000) Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer 85:35–39PubMedCrossRef

Madeleine MM, Anttila T, Schwartz SM, Saikku P, Leinonen M, Carter JJ, Wurscher M, Johnson LG, Galloway DA, Daling JR (2007) Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors. Int J Cancer 120:650–655PubMedCrossRef

Risch HA, Howe GR (1995) Pelvic inflammatory disease and the risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 4:447–451PubMed

Boom R, Sol CJA, Salimans MMM, Jansen CL, Wertheim-van Dillen PM, van der Noordaa J (1990) Rapid and simple method for purification of nucleic acids. J Clin Microbiol 28:495–503PubMed

Høgdall EVS, Kjaer SK, Blaakaer J, Christensen L, Glud E, Vuust J, Høgdall CK (2006) P53 mutations in tissue from Danish ovarian cancer patients: from the Danish “MALOVA” ovarian cancer study. Gynecol Oncol 100:76–82PubMedCrossRef

10.

Bauer HM, Greer CE, Manos MM (1992) Determination of genital HPV infection using consensus PCR. In: Herrington CS, McGee JOD (eds) Diagnostic molecular pathology: a practical approach. Oxford University Press, Oxford, pp 131–152

11.

Bauer HM, Hildesheim A, Schiffman MH, Glass AG, Rush BB, Scott DR, Cadell DM, Kurman RJ, Manos MM (1993) Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Trans Dis 20:274–278CrossRef

12.

de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ (1995) The use of general primers GP5 and GP6 elongated at their 3’ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76:1057–1062PubMedCrossRef

13.

Mahony JB, Luinstra KE, Jang D, Sellors J, Chernesky MA (1992) Chlamydia trachomatis confirmatory testing of PCR-positive genitourinary specimens using a second set of plasmid primers. Mol Cell Probes 6:381–388PubMedCrossRef

14.

Kuhn DE, Beall CJ, Kolattukudy PE (1995) The cytomegalovirus US28 protein binds multiple CC chemokines with high affinity. Biochem Biophys Res Commun 211:325–330PubMedCrossRef

15.

Gupta J, Pilotti S, Rilke F, Shah K (1987) Association of human papillomavirus type 16 with neoplastic lesions of the vulva and other genital sites by in situ hybridization. Am J Pathol 127:206–215PubMed

16.

Shah KV, Howley PM (1996) Papillomaviruses. In: Fields BN, Knipe DM, Howley PM (eds) Fields virology, vol 2. Lippincott-Raven, Philadelphia, pp 2077–2109

17.

Dillner J, Lehtinen M, Björge T, Luostarinen T, Youngman L, Jellum E, Koskela P, Gislefoss RE, Hallmans G, Paavonen J, Sapp M, Schiller JT, Hakulinen T, Thoresen S, Hakama M (1997) Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer. J Natl Cancer Inst 89:1293–1299PubMedCrossRef

18.

Runnebaum IB, Maier S, Tong XW, Rosenthal HE, Möbus VJ, Kieback DG, Kreienberg R (1995) Human papillomavirus integration is not associated with advanced epithelial ovarian cancer in German patients. Cancer Epidemiol Biomarkers Prev 4:573–575PubMed

19.

Trottier AM, Provencher D, Mes-Masson AM, Vauclair R, Coutlée F (1995) Absence of human papillomavirus sequences in ovarian pathologies. J Clin Microbiol 33:1011–1013PubMed

20.

Wu QJ, Guo M, Lu ZM, Li T, Qiao HZ, Ke Y (2003) Detection of human papillomavirus-16 in ovarian malignancy. Br J Cancer 89:672–675PubMedCrossRef

21.

Idahl A, Lundin E, Elgh F, Jurstrand M, Møller JK, Marklund I, Lindgren P, Ottander U (2010) Chlamydia trachomatis, Mycoplasma genitalium, Neisseria gonorrhoeae, human papillomavirus, and polyomavirus are not detectable in human tissue with epithelial ovarian cancer, borderline tumor, or benign conditions. Am J Obstet Gynecol 202:71.e1–71.e6CrossRef

22.

Dürst M, Kleinheinz A, Hotz M, Gissmann L (1985) The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. J Gen Virol 66:1515–1522PubMedCrossRef

23.

Galehouse D, Jenison E, DeLucia A (1992) Differences in the integration pattern and episomal forms of human papillomavirus type 16 DNA found within an invasive cervical neoplasm and its metastasis. Virology 186:339–341PubMedCrossRef

24.

Gissmann L, Wolnik L, Ikenberg H, Koldovsky U, Schnürch HG, zur Hausen H (1983) Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Nat Acad Sci USA 80:560–563PubMedCrossRef

25.

Boshart M, zur Hausen H (1986) Human papillomaviruses in Buschke–Löwenstein tumors: physical state of the DNA and identification of a tandem duplication in the noncoding region of a human papillomavirus 6 subtype. J Virol 58:963–966PubMed

26.

Rando RF, Sedlacek TV, Hunt J, Jenson AB, Kurman RJ, Lancaster WD (1986) Verrucous carcinoma of the vulva associated with an unusual type 6 human papillomavirus. Obstet Gynecol 67:70S–75SPubMedCrossRef

27.

Byrne JC, Tsao MS, Fraser RS, Howley PM (1987) Human papillomavirus-11 DNA in a patient with chronic laryngotracheobronchial papillomatosis and metastatic squamous-cell carcinoma of the lung. N Engl J Med 317:873–878PubMedCrossRef

28.

Manias DA, Ostrow RS, Mcglennen RC, Estensen RD, Faras AJ (1989) Characterization of integrated human papillomavirus type 11 DNA in primary and metastatic tumors from a renal transplant recipient. Cancer Res 49:2514–2519PubMed

29.

Bercovich JA, Centeno CR, Aguilar OG, Grinstein S, Kahn T (1991) Presence and integration of human papillomavirus type 6 in a tonsillar carcinoma. J Gen Virol 72:2569–2572PubMedCrossRef

30.

Lee JW, Choi CH, Choi JJ, Park YA, Kim SJ, Hwang SY, Kim WY, Kim TJ, Lee JH, Kim BG, Bae DS (2008) Altered microRNA expression in cervical carcinomas. Clin Cancer Res 14:2535–2542PubMedCrossRef

31.

Mitao M, Reumann W, Winkler B, Richart RM, Fujiwara A, Crum CP (1984) Chlamydial cervicitis and cervical intraepithelial neoplasia: an immunohistochemical analysis. Gynecol Oncol 19:90–97PubMedCrossRef

32.

Kiviat NB, Paavonen JA, Brockway J, Critchlow CW, Brunham RC, Stevens CE, Stamm WE, Kuo CC, DeRouen T, Holmes KK (1985) Cytologic manifestations of cervical and vaginal infections. I. Epithelial and inflammatory cellular changes. JAMA 253:989–996PubMedCrossRef

33.

Fan T, Lu H, Hu H, Shi L, McClarty GA, Nance DM, Greenberg AH, Zhong G (1998) Inhibition of apoptosis in Chlamydia-infected cells: blockade of mitochondrial cytochrome C release and caspase activation. J Exp Med 187:487–496PubMedCrossRef

34.

Felley-Bosco E (1998) Role of nitric oxide in genotoxicity: implication for carcinogenesis. Cancer Metastasis Rev 17:25–37PubMedCrossRef

35.

Castle PE, Hillier SL, Rabe LK, Hildesheim A, Herrero R, Bratti MC, Sherman ME, Burk RD, Rodriguez AC, Alfaro M, Hutchinson ML, Morales J, Schiffman M (2001) An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev 10:1021–1027PubMed

36.

Prozialeck WC, Fay MJ, Lamar PC, Pearson CA, Sigar I, Ramsey KH (2002) Chlamydia trachomatis disrupts N-cadherin-dependent cell–cell junctions and sequesters beta-catenin in human cervical epithelial cells. Infect Immun 70:2605–2613PubMedCrossRef

37.

Sharma TM, Nadasdy T, Leech RW, Kingma DW, Johnson LD, Hanson-Painton O (1994) In situ DNA hybridization study of ‘primary’ cytomegalovirus (CMV) oophoritis. Acta Obstet Gynecol Scand 73:429–431PubMedCrossRef

38.

Manfredi R, Alampi G, Talò S, Calza L, Tadolini M, Martinelli GN, Chiodo F (2000) Silent oophoritis due to cytomegalovirus in a patient with advanced HIV disease. Int J STD AIDS 11:410–412PubMedCrossRef

39.

Yu J, Solano FX Jr, Seethala RR (2007) Bilateral cytomegalovirus (CMV) oophoritis mimicking widely metastatic carcinoma: a case report and review of the literature. Diagn Pathol 2:50PubMedCrossRef

40.

Hendrix RM, Wagenaar M, Slobbe RL, Bruggeman CA (1997) Widespread presence of cytomegalovirus DNA in tissues of healthy trauma victims. J Clin Pathol 50:59–63PubMedCrossRef

Title: Viral and bacterial aetiologies of epithelial ovarian cancer
Authors: S. Shanmughapriya
G. SenthilKumar
K. Vinodhini
B. C. Das
N. Vasanthi
K. Natarajaseenivasan
Publication date: 01-09-2012
Publisher: Springer-Verlag
Published in: European Journal of Clinical Microbiology & Infectious Diseases / Issue 9/2012
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-012-1570-5

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 9/2012

Clinical and economic impact of rapid reporting of bacterial identification and antimicrobial susceptibility results of the most frequently processed specimen types

Previous healthcare exposure is the main antecedent for methicillin-resistant Staphylococcus aureus carriage on hospital admission in Belgium

Long-term trends in the epidemiology of human leptospirosis (Slovak Republic, 1954–2006)

Listeriosis in pregnancy: a secular trend in a tertiary referral hospital in Barcelona

Comparison of an in-house method and the commercial Sepsityper™ kit for bacterial identification directly from positive blood culture broths by matrix-assisted laser desorption-ionisation time-of-flight mass spectrometry

Identification of Francisella tularensis by both culture and real-time TaqMan PCR methods from environmental water specimens in outbreak areas where tularemia cases were not previously reported

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials